BCPC
BALCHEM CORP
Key Financials
Gross Profit
$370.6M
↑ 294.7%
Revenue
$1.0B
↑ 293.4%
Net Income
$154.8M
↑ 294.8%
Operating Income
$209.3M
↑ 14.4%
Shareholders' Equity
$1.3B
↑ 9.3%
Total Assets
$1.7B
↑ 7.0%
Total Liabilities
$428.8M
↑ 0.8%
EPS (Diluted)
$4.75
↑ 292.6%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| 3 | 4/7/2026 | View on SEC |
| SCHEDULE 13G/A | 3/26/2026 | View on SEC |
| 10-K | 2/20/2026 | View on SEC |
| 8-K | 2/20/2026 | View on SEC |
| 8-K | 2/19/2026 | View on SEC |
| 4 | 2/13/2026 | View on SEC |
| 4 | 2/13/2026 | View on SEC |
| 4 | 2/13/2026 | View on SEC |
| 4 | 2/13/2026 | View on SEC |
| 4 | 2/13/2026 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | BCPC |
| Company Name | BALCHEM CORP |
| CIK | 9326 |
| Sector | Chemicals & Allied Products |
| Industry | Large accelerated filer |
| Exchange | Nasdaq |
| SIC Code | 2800 |
| SIC Description | Chemicals & Allied Products |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | MD |
| Phone | (845) 326-5600 |